Guardant Health, Inc. (GH) — Not yet assessed · Company page | HillSignal
Verified IDGH · Nasdaq
Guardant Health, Inc.
Services-Medical Laboratories.
Company page · Records as of 17 Nov 2026
Revenue
$1.3B
12 months to Sep 2026
Money
Revenue and federal contracts, by year
Contracts obligated, federal fiscal yearCompany revenue, its fiscal year ending that year (10-K)
FY2026$0$982M
FY2025$0$739M
FY2024$0$564M
FY2023$0$450M
FY2022$0$374M
Committed contract money is not revenue: a multi-year contract can be funded in one year. Prime contracts only; subcontracts and classified work are not included.
Influence
Lobbying
Filings
49
Latest year
2026
Issues
Budget/Appropriations
Health Issues
Medical/Disease Research/Clinical Labs
Medicare/Medicaid
Lobbyists who held government posts
Jennifer Rachel LeibFellow, Senate Committee on Health, Education, Labor, and Pensions
Nicholas UehleckeSenior Advisor, Dept. of Health and Human ServicesProfessional Staff/Sr. Legislative Assistant, House Ways and Means Subcommittee
Paul EdattelChief Health Counsel, House Energy & Commerce CommitteePolicy Assistant, Office of the Speaker+2 more postsChief Health Counsel, House Energy & Commerce CommitteePolicy Assistant, Office of the SpeakerProfessional Staff Member for the Majority at the House Energy & Commerce CommitteeLegislative Assistant & Legislative Director, Rep. John Shadegg
Daniel M ToddSenior Health Counsel, Senate Finance CommitteeSpecial Assistant, Office of Admin. Ct. - Medicare & Medicaid
People
Key people
Kevin R. SayerDirector
Robert ParksChief Accounting Officer
Darya ChudovaChief Technology Officer
Michael Brian BellChief Financial Officer
Terilyn J. MonroeChief People Officer
Helmy EltoukhyCo-Chief Executive Officer
Chris FreemanChief Commercial Officer
Meghan Joyce VDirector
Vijaya GaddeDirector
Roberto MignoneDirector
Myrtle S. PotterDirector
Medina Manuel HidalgoDirector
Ian T. ClarkDirector
Alex M. AzarDirector
Musa TariqDirector
Connections
Shared personDEXCOM INC ($DXCM)SAYER KEVIN R is Director at one entity and Executive Chair at the other
$10KAlex M. Azar II, Director: sold16 Nov 2026 · Source
$19KMusa Tariq, Director: sold16 Oct 2026 · Source
$11KAlex M. Azar II, Director: sold14 Oct 2026 · Source
$632KKumud Kalia, Chief Information Officer: sold11 Sep 2026 · Source
$8.7MTerilyn J. Monroe, Chief People Officer: sold12 Aug 2026 · Source
$15.5MChris Freeman, Chief Commercial Officer: sold10 Aug 2026 · Source
Activity
Patents (1 on file)
20 Oct 2026METHODS FOR FRAGMENTOME PROFILING OF CELL-FREE NUCLEIC ACIDSUS 12770714
From a USPTO sample of recent grants in strategic technology areas, not a full patent database: a missing patent here is not proof there is none.
Sources
Where the records come from
Federal contracts
USAspending award records (fiscal 2025 onward), linked by contractor ID
Purchase notices
SAM.gov
Lobbying
Senate Lobbying Disclosure Act filings
Political giving
Federal Election Commission (FEC)
Insider trades
SEC Form 4
Revenue
SEC filings (10-K, 10-Q)
Private raises
SEC Form D
Patents
USPTO, a sample of recent grants in strategic technology areas
Congressional trades
House and Senate financial disclosures
Every record on this page links to its source.
Committed contract money is not revenue.
Records as of 17 Nov 2026; revenue for the 12 months to Sep 2026.
Ask Intel
Source-backed
Edward Abry Waters
Legislative Assistant to Rep. Timothy Bishop (NY-01)
NICHOLAS WILLIAM BATH jrHealth Policy Director of the U.S. Senate Committee on Health, Education, Lab…Full textHealth Policy Director of the U.S. Senate Committee on Health, Education, Labor and Pensions
Stephen WeylerHealth and Labor Fellow, U.S. House of Representatives, Committee on Educatio…Full textHealth and Labor Fellow, U.S. House of Representatives, Committee on Education & Labor (2019)
James ObrienPro. Staff Member, Ways and Means Committee (22-23)Rep Kevin Brady: Leg. Dir. (21-22)+4 more postsPro. Staff Member, Ways and Means Committee (22-23)Rep Kevin Brady: Leg. Dir. (21-22)Sr. Leg. Asst (19-21)Sen Mitch McConnell: Leg. Correspondent (18-19)Staff Asst (17-18)Intern (16)
Christopher GillottSen. Bill Cassidy: Deputy Chief of Staff, Policy (2018-2021)Legislative Dir (2013-2021)+4 more postsSen. Bill Cassidy: Deputy Chief of Staff, Policy (2018-2021)Legislative Dir (2013-2021)Sr Legislative Asst (2013)Rep. Bobby Jindal: Leg. Dir (2007-2008)Sr Legislative Asst (2005-2007)Sen. Kay Bailey Hutchison: Leg Aide (2003-2005)
Heide BajnrauhSen. McCain Intern 94-96LSA96-97
Drew GriffinChief of Staff, Rep. Robert Latta (2019-2022)Comms Dir, Rep. Robert Latta (2016-2019)+3 more postsChief of Staff, Rep. Robert Latta (2019-2022)Comms Dir, Rep. Robert Latta (2016-2019)Press Sec, Rep. Erik Paulsen (2014-2016)Press Sec, Rep. Jaime Herrera Beutler (2013-2014)Staff Asst, Rep. Jaime Herrera Beutler (2011-2013)
Kathryn WiseLeg. Dir, Rep. Vern Buchanan (2014-2015)Leg. Dir, Rep. Mike Fitzpatrick (2013-2014)+3 more postsLeg. Dir, Rep. Vern Buchanan (2014-2015)Leg. Dir, Rep. Mike Fitzpatrick (2013-2014)Sr. Legislative Asst, Rep. Mike Fitzpatrick (2011-2013)Legislative Correspondent/Asst, Rep. Mary Fallin (2010-2011)Staff Asst, Rep. Mary Fallin (2009-2010)
Joyce Meghan V is Director at one entity and Director at the other
Disclosed tradeJonathan JacksonJonathan Jackson disclosed a purchase in GH